BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 22959702)

  • 1. Impact of multiple antigenic epitopes from ApoB100, hHSP60 and Chlamydophila pneumoniae on atherosclerotic lesion development in Apob(tm2Sgy)Ldlr(tm1Her)J mice.
    Lu X; Xia M; Endresz V; Faludi I; Szabo A; Gonczol E; Mundkur L; Chen D; Kakkar V
    Atherosclerosis; 2012 Nov; 225(1):56-68. PubMed ID: 22959702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization with a combination of 2 peptides derived from the C5a receptor significantly reduces early atherosclerotic lesion in Ldlr(tm1Her) Apob(tm2Sgy) J mice.
    Lu X; Xia M; Endresz V; Faludi I; Mundkur L; Gonczol E; Chen D; Kakkar VV
    Arterioscler Thromb Vasc Biol; 2012 Oct; 32(10):2358-71. PubMed ID: 22837469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of recombinant antigenic constructs containing multi-epitopes towards effective reduction of atherosclerotic lesion in B6;129S-Ldlr(tm1Her)Apob(tm2Sgy)/J mice.
    Xia M; Chen D; Endresz V; Lantos I; Szabo A; Kakkar V; Lu X
    PLoS One; 2015; 10(4):e0123393. PubMed ID: 25830298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization of Chlamydia pneumoniae (Cpn)-infected Apob(tm2Sgy)Ldlr(tm1Her)/J mice with a combined peptide of Cpn significantly reduces atherosclerotic lesion development.
    Xia M; Chen D; Endresz V; Faludi I; Szabo A; Gonczol E; Kakkar V; Lu X
    PLoS One; 2013; 8(12):e81056. PubMed ID: 24349031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ApoB-100 and HSP60 peptides exert a synergetic role in inhibiting early atherosclerosis in immunized ApoE-null mice.
    Li J; Zhao X; Zhang S; Wang S; Du P; Qi G
    Protein Pept Lett; 2011 Jul; 18(7):733-40. PubMed ID: 21413922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune regulation by oral tolerance induces alternate activation of macrophages and reduces markers of plaque destabilization in Apob
    Thota LN; Ponnusamy T; Philip S; Lu X; Mundkur L
    Sci Rep; 2017 Jun; 7(1):3997. PubMed ID: 28638138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Efficacy and Safety of Immunomodulatory Therapy for Atherosclerosis.
    Thota LN; Ponnusamy T; Lu X; Mundkur L
    Cardiovasc Drugs Ther; 2019 Aug; 33(4):385-398. PubMed ID: 31332656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization with a combination of ApoB and HSP60 epitopes significantly reduces early atherosclerotic lesion in Apobtm2SgyLdlrtm1Her/J mice.
    Lu X; Chen D; Endresz V; Xia M; Faludi I; Burian K; Szabo A; Csanadi A; Miczak A; Gonczol E; Kakkar V
    Atherosclerosis; 2010 Oct; 212(2):472-80. PubMed ID: 20609438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucosal tolerance to a combination of ApoB and HSP60 peptides controls plaque progression and stabilizes vulnerable plaque in Apob(tm2Sgy)Ldlr(tm1Her)/J mice.
    Mundkur L; Mukhopadhyay R; Samson S; Varma M; Kale D; Chen D; Shivaprasad S; Sivanandan H; Soman V; Lu X; Kakkar VV
    PLoS One; 2013; 8(3):e58364. PubMed ID: 23505495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination against T-cell epitopes of native ApoB100 reduces vascular inflammation and disease in a humanized mouse model of atherosclerosis.
    Gisterå A; Hermansson A; Strodthoff D; Klement ML; Hedin U; Fredrikson GN; Nilsson J; Hansson GK; Ketelhuth DF
    J Intern Med; 2017 Apr; 281(4):383-397. PubMed ID: 28194913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD8+ T cells specific for a potential HLA-A*0201 epitope from Chlamydophila pneumoniae are present in the PBMCs from infected patients.
    Carralot JP; Dumrese C; Wessel R; Riessen R; Autenrieth I; Walter S; Schoor O; Stevanovic S; Rammensee HG; Pascolo S
    Int Immunol; 2005 May; 17(5):591-7. PubMed ID: 15802306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chlamydial and human heat shock protein 60 homologues in acute coronary syndromes. (Auto-)immune reactions as a link between infection and atherosclerosis].
    Andrié R; Braun P; Welsch U; Straube E; Höpp HW; Erdmann E; Lüderitz B; Bauriedel G
    Z Kardiol; 2003 Jun; 92(6):455-65. PubMed ID: 12819994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulating Inflammatory Immune Response to Atherogenic Antigens Prevents Development and Progression of Atherosclerosis in New Zealand White Rabbits.
    Philip S; Ponnusamy T; Rao LN; Biradar S; Kumar R; Deshpande V; Lu X; Kakkar VV; Mundkur LA
    Can J Cardiol; 2016 Aug; 32(8):1008.e1-1008.e10. PubMed ID: 27062234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory CD4
    Kimura T; Kobiyama K; Winkels H; Tse K; Miller J; Vassallo M; Wolf D; Ryden C; Orecchioni M; Dileepan T; Jenkins MK; James EA; Kwok WW; Hanna DB; Kaplan RC; Strickler HD; Durkin HG; Kassaye SG; Karim R; Tien PC; Landay AL; Gange SJ; Sidney J; Sette A; Ley K
    Circulation; 2018 Sep; 138(11):1130-1143. PubMed ID: 29588316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the target for therapeutic recombinant anti-apoB-100 peptide antibodies in human atherosclerotic lesions.
    Gonçalves I; Nitulescu M; Ares MP; Fredrikson GN; Jansson B; Li ZC; Nilsson J
    Atherosclerosis; 2009 Jul; 205(1):96-100. PubMed ID: 19150065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-P. gingivalis response correlates with atherosclerosis.
    Ford PJ; Gemmell E; Timms P; Chan A; Preston FM; Seymour GJ
    J Dent Res; 2007 Jan; 86(1):35-40. PubMed ID: 17189460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral dosing with multi-antigenic construct induces atheroprotective immune tolerance to individual peptides in mice.
    Mundkur L; Ponnusamy T; Philip S; Rao LN; Biradar S; Deshpande V; Kumar R; Lu X; Kakkar VV
    Int J Cardiol; 2014 Aug; 175(2):340-51. PubMed ID: 24962340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated antibody levels against Chlamydia pneumoniae, human HSP60 and mycobacterial HSP65 are independent risk factors in myocardial infarction and ischaemic heart disease.
    Heltai K; Kis Z; Burian K; Endresz V; Veres A; Ludwig E; Gönczöl E; Valyi-Nagy I
    Atherosclerosis; 2004 Apr; 173(2):339-46. PubMed ID: 15064111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal immunization with an apolipoprotein B-100 fusion protein induces antigen-specific regulatory T cells and reduces atherosclerosis.
    Klingenberg R; Lebens M; Hermansson A; Fredrikson GN; Strodthoff D; Rudling M; Ketelhuth DF; Gerdes N; Holmgren J; Nilsson J; Hansson GK
    Arterioscler Thromb Vasc Biol; 2010 May; 30(5):946-52. PubMed ID: 20167655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of apoB-100 Peptide-Specific CD8+ T Cells in Atherosclerosis.
    Dimayuga PC; Zhao X; Yano J; Lio WM; Zhou J; Mihailovic PM; Cercek B; Shah PK; Chyu KY
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28711866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.